Veriheal

MARCH 21, 2022

Cannabis companies that hire drivers to work for them—such as delivery services and goods transporters—are being advised by the Centers for Disease Control and Prevention (CDC) to establish certain policies that can mitigate the risk of impaired driving, all the while ensuring that companies remain in alignment with state legalization laws.

Policy 94

Policy Blood Pressure Research and Development Concentrates 94

Cannabis Law Report

MARCH 16, 2022

This paper is the first as part of a new research project, supported by Juul Labs , focusing on developing a new approach to regulation of the vaping industry in the UK. Access Rights Type : open. PUBLICATION DETAILS. Copyright : Demos 2022. Post date : 16 Mar 2022. apo-nid316926.

Vaping 98

Vaping Policy Research and Development Access 98

Cannabis Law Report

AUGUST 20, 2022

CRCC’s paper, published by the Ohio State University (OSU) Moritz College of Law, is titled “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”. Ohio State Legal Studies Research Paper No. Drug Enforcement and Policy Center, August, 2022. Ohio State Legal Studies Research Paper No.

Banking 52

Banking Access Research and Development Policy 52

MMJ Recs

FEBRUARY 10, 2024

Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views. Understanding the specifics of Ohio’s medical cannabis legislation is crucial to appreciating the strides made in facilitating patient access to this alternative form of medicine.

Research and Development 105

Research and Development Marijuana History Legislation 105

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . This new program is being funded by private investors, including Matt Wullenweg, developer of WordPress, and philanthropist Tim Ferriss. Professor of Law at Harvard Law School.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Opportunities for Federal Support of Psychedelics Research. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Veriheal

FEBRUARY 14, 2024

The board will work on projects like designing the training program for psychedelic facilitators, tracking psychedelic policy development, studying ongoing science related to psilocybin, and making recommendations to lawmakers regarding the bill. People will not have to meet specific qualifications to access care.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 172

DEA Research and Development Clinical Trials Marijuana 172

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Americans for Safe Access

MAY 21, 2019

Americans for Safe Access Wants to Help You Navigate the Federal Regulatory Process. In fact, the FDA itself specifies that the FDA comment process is not a popularity contest in which the agency will adopt the policy position promoted by the greatest number of commenters.

Research and Development 149

Research and Development Policy Food Programs 149

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Americans for Safe Access

OCTOBER 26, 2021

Check out the October 2021 issue of the ASA Activist Newsletter for updates on developments that matter for medical cannabis advocates, including Congressional action on the revived MORE Act that could end federal prohibition. In the activist profile, you'll learn about Michelle J.

Research and Development 130

Research and Development Education Events Policy 130

Veriheal

DECEMBER 9, 2021

When cannabis legalization began to gain ground and support, those who remained opposed to these policy changes touted claims that legalization would increase the risk of mental illness or even suicide among affected populations. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies.

Legalization 98

Legalization Research and Development Consumption Recreational 98

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. These interactions may contribute to the development of cannabis-induced psychosis.

Research and Development 52

Research and Development Treatment Conditions Education 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Cannabis Law Report

SEPTEMBER 9, 2021

The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Central Research Question.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

United Patients Group

JANUARY 4, 2024

These roles complement healthcare practitioners’ vital work and shape the future of healthcare delivery, policy, and administration. Tasked with overseeing budgets, managing personnel, and implementing policies, healthcare administrators are instrumental in maintaining the integrity of healthcare delivery systems.

Research and Development 52

Research and Development Patients Data Policy 52

NORML

FEBRUARY 15, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of medical marijuana access. AL resident? KY resident? MD resident?

Legislation 275

Legislation Decriminalization Access Patients 275

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

United Patients Group

JUNE 26, 2023

They often possess a more profound understanding of healthcare policies, advanced practice procedures, and innovative research methodologies. These comprehensive programs focus on developing skills in patient care, policy interpretation, and research methods. Here, nurses have the potential to bridge the gap.

Research and Development 52

Research and Development Education Patients Policy 52

Veriheal

NOVEMBER 8, 2022

A team of researchers wanted to assess the impact of recreational cannabis legalization on obesity, beginning by stating, “obesity in the US arguably constitutes the most significant health epidemic over the past century.” Adult-use Legalization is Associated with Decreased Levels of Obesity.

Research and Development 98

Research and Development Consumption Recreational Food 98

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

JANUARY 27, 2022

If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session.

Research and Development 52

Research and Development Policy Access Legislation 52

MMJ Recs

MARCH 20, 2024

Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. End cannabis prohibition, the market for these products will go away and these compounds will be relegated to research labs, where they belong, not the marketplace. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Legislation is pending, HB 350, to expand medical cannabis access. NH resident? GA resident?

Legislation 128

Legislation Clinical Trials Research and Development Access 128

Cannabis Law Report

JUNE 20, 2021

Patient access. I’ve been working hard with some great advocates for patient access in the UK and this position will give me the opportunity to ensure that patients will have access to the high-quality medicines and products they deserve.”.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

WeedAdvisor

MAY 9, 2019

Thankfully, world-famous singer Olivia Newton-John wants to see easier access to medical marijuana in Australia, according to Australian publication The New Daily. Olivia Newtwon-John is particularly taken aback by the access issue. With a few exceptions, celebrity endorsements are a great thing for any commodity or cause.

Access 49

Access Marijuana Terpenes Research and Development 49

WeedAdvisor

FEBRUARY 25, 2019

From opt-outs to gross limitations on the number of initial cannabis stores, “competent” is hardly a word we could use to describe Ontario’s marijuana policy. As for instant delivery, this service would also be pivotal in improving accessibility. Lack of Accessibility Boosts Black Market.

Policy 40

Policy Legalization Collective Access 40

Cannabis Law Report

OCTOBER 4, 2021

To ensure that you will receive access to the livestream and be kept up to date on any changes to the event, register now. On June 30, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced a new research initiative, the Project on Psychedelics Law and Regulation (POPLAR).

Law 52

Law Advocacy Research and Development Events 52

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. The final part of the resolution discusses the need to support research into cannabis.

Policy 40

Policy Research and Development Marijuana DEA 40